Patents Assigned to Cumberland Swan Holdings, Inc.
  • Patent number: 6514537
    Abstract: A magnesium citrate oral solution comprising citric acid in an amount greater than 10% weight/volume; magnesium hydroxide in an amount ranging from about 1.5-5% weight/volume; and water. Most preferably, the citric acid is present in an amount of about 10.9% weight/volume. Another embodiment of the present invention is a method of treating constipation in a patient in need thereof. The method of this embodiment comprises administering an effective amount of an oral composition that comprises citric acid in an amount greater than 10% weight/volume. Preferably, the composition of this embodiment comprises citric acid in an amount of 10.9% weight/volume.
    Type: Grant
    Filed: May 29, 2001
    Date of Patent: February 4, 2003
    Assignee: Cumberland Swan Holdings, Inc.
    Inventor: William R. Murphy
  • Patent number: D554517
    Type: Grant
    Filed: April 17, 2006
    Date of Patent: November 6, 2007
    Assignee: Cumberland Swan Holdings, Inc.
    Inventor: Kurt V. Breitlander
  • Patent number: D559114
    Type: Grant
    Filed: April 17, 2006
    Date of Patent: January 8, 2008
    Assignee: Cumberland Swan Holdings, Inc.
    Inventor: Kurt V. Breitlander
  • Patent number: D433637
    Type: Grant
    Filed: May 28, 1999
    Date of Patent: November 14, 2000
    Assignee: Cumberland Swan Holdings, Inc.
    Inventors: Terry L. Hailey, Joseph G. Roddy, Rita R. Libell-Caldwell